The International Center for Polyamine Disorders (ICPD) is a collaborative translational and clinical research program operated under the auspices of Michigan State University and Spectrum Health West Michigan in Grand Rapids, Michigan. The ICPD launched in summer 2020 and includes a polyaminopathy patient biobank, a state-of-the-art translational research lab core and a clinical genetics team at Spectrum Health West Michigan. The ICPD offers innovative ways to study polyaminopathies, associated disabilities and develop strategies for treatment and prevention. This collaborative effort between Spectrum Health and Michigan State University brings world leading experts in the field from the bench and clinic together to study these rare genetic diseases.
Caleb Bupp, MD, FACMG, Clinical Director ICPD, Section Chief – Medical Genetics and Genomics at Helen DeVos Children’s Hospital
Surender Rajasekaran, MD, Research Director ICPD, Medical Director of Research at Spectrum Health West Michigan
Andre Bachmann, PhD, Scientific Director ICPD, Professor, Associate Chair for Research in the Department of Pediatrics and Human Development and Michigan State University faculty
Charles E. Schwartz, PhD, Assistant Research Director ICPD, Chair Medical and Scientific Advisory Board Snyder Robinson Foundation and Adjunct Professor, Department of Pediatrics and Human Development, Michigan State University
The ICPD is pleased to announce that we will be hosting a collaborative conference in Grand Rapids, Michigan from Monday, June 17 to Tuesday, June 18, 2024. Registration is free, but is required for attendance. Please register here before May 1. We look forward to seeing you in Grand Rapids!